Objective: To evaluate the usefulness of the diagnostic tests recommended by the European Society of Hypertension/Cardiology Guidelines (ESH-ESC 2007) in hypertensive patients classified as being at low or moderate risk, analyzing the change to high risk classification and the characteristics associated with such change.
Methods: A cross-sectional study was made in 391 patients aged between 30 and 80 years recently diagnosed with arterial hypertension in the Primary Care setting. The criteria of the 2007 ESH-ESC Guidelines were followed for the evaluation of risk factors, subclinical organ damage, cardiovascular disease and cardiovascular risk. In addition to the routine tests, echocardiography, carotid ultrasound, albumin/creatinine ratio, estimated glomerular filtration rate, ankle-brachial index, pulse wave velocity and retinography were used. We established four levels of testing performed for risk classification.
Results: Using the routine tests to evaluate risk (level 1), 218 (55.8%) patients were classified as being at high risk. Of the 173 patients classified as presenting low or moderate risk, the ankle-brachial index, albumin/creatinine ratio and glomerular filtration rate were determined (level 2), and 18 patients (10.4%) were classified as being at high risk. With echocardiography and carotid ultrasound (level 3), another 16 patients (10%) were raised to high risk. Finally, with pulse wave velocity and retinography (level 4), 10 additional patients (5%) were classified as presenting high risk. Patients with increased blood pressure, advanced age and women showed a 4.28-fold (95%CI: 2.01–9.16), 3.54-fold (95%CI: 1.61–7.77) and 1.36-fold (95%CI: 0.62–3.00) higher probability of being reclassified to high cardiovascular risk, respectively.
Conclusions: With the non-routine tests, 25.4% of the low or moderate risk patients were reclassified as presenting high risk.
ManciaGDe BackerGDominiczakACifkovaRFagardRGermanoG. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens2007; 25: 1105–1187.
AchterbergSCramerMJKappelleLJde BorstGJVisserenFLvan der GraafY. Patients with coronary, cerebrovascular or peripheral arterial obstructive disease differ in risk for new vascular events and mortality: the SMART study. Eur J Cardiovasc Prev Rehabil2010; 17: 424–430.
4.
RahmanMPresselSDavisBRNwachukuCWrightJTJrWheltonPK. Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann Intern Med2006; 144: 172–180.
5.
WachtellKIbsenHOlsenMHBorch-JohnsenKLindholmLHMogensenCE. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med2003; 139: 901–906.
6.
LonnEMathewJPogueJJohnstoneDDanisaKBoschJ. Relationship of electrocardiographic left ventricular hypertrophy to mortality and cardiovascular morbidity in high-risk patients. Eur J Cardiovasc Prev Rehabil2003; 10: 420–428.
7.
LeonciniGSacchiGViazziFRaveraMParodiDRattoE. Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach. J Hypertens2002; 20: 1315–1321.
8.
CuspidiCAmbrosioniEManciaGPessinaACTrimarcoBZanchettiA. Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey. J Hypertens2002; 20: 1307–1314.
9.
O'BrienEAsmarRBeilinLImaiYManciaGMengdenT. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens2005; 23: 697–701.
10.
Salas-SalvadoJRubioMABarbanyMMorenoB. SEEDO 2007 Consensus for the evaluation of overweight and obesity and the establishment of therapeutic intervention criteria. Med Clin (Barc)2007; 128: 184–196.
11.
CockcroftDWGaultMH. Prediction of creatinine clearance from serum creatinine. Nephron1976; 16: 31–41.
12.
LeveyASBoschJPLewisJBGreeneTRogersNRothD. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med1999; 130: 461–470.
13.
SchillerNBShahPMCrawfordMDeMariaADevereuxRFeigenbaumH. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr1989; 2: 358–367.
14.
DevereuxRBAlonsoDRLutasEMGottliebGJCampoESachsI. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol1986; 57: 450–458.
15.
OkinPMRomanMJDevereuxRBKligfieldP. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol1995; 25: 417–423.
16.
TouboulPJHennericiMGMeairsSAdamsHAmarencoPBornsteinN. Mannheim carotid intima-media thickness consensus (2004–2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis2007; 23: 75–80.
17.
KeithNMWagenerHPBarkerNW. Some different types of essential hypertension: their course and prognosis. Am J Med Sci1974; 268: 336–345.
18.
ViazziFLeonciniGParodiDRattoEVettorettiSVaccaroV. Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension. J Am Soc Nephrol2005; 16 Suppl 1: S89–S91.
19.
ViazziFParodiDLeonciniGVettorettiSRattoEVaccaroV. Optimizing global risk evaluation in primary hypertension: the role of microalbuminuria and cardiovascular ultrasonography. J Hypertens2004; 22: 907–913.
20.
de la SierraAEgocheagaMIAguileraMT. Prevalence and clinical characteristics of microalbuminuria in the Spanish hypertensive population. Med Clin (Barc)2008; 130: 201–205.
21.
LahozCMostazaJMMantillaMTTaboadaMTrancheSMartin-JadraqueR. Occult chronic kidney disease in patients with stable coronary heart disease. Med Clin (Barc)2008; 131: 241–244.
22.
GuoWWLiJYuJMLuoYYLiuHZhengLQ. The relationship of ankle brachial index to all-cause and cardiovascular disease mortality in Chinese male patients with hypertension. Zhonghua Yu Fang Yi Xue Za Zhi2007; 41: 487–491.
23.
KarthikeyanVJLipGY. Peripheral artery disease and hypertension: the relation between ankle-brachial index and mortality. J Hum Hypertens2007; 21: 762–765.
24.
LuoYYLiJXinYZhengLQYuJMHuDY. Risk factors of peripheral arterial disease and relationship between low ankle brachial index and mortality from all-cause and cardiovascular disease in Chinese patients with hypertension. J Hum Hypertens2007; 21: 461–466.
25.
CuspidiCMeaniSValerioCFusiVSalaCZanchettiA. Left ventricular hypertrophy and cardiovascular risk stratification: impact and cost-effectiveness of echocardiography in recently diagnosed essential hypertensives. J Hypertens2006; 24: 1671–1677.
Willum-HansenTStaessenJATorp-PedersenCRasmussenSThijsLIbsenH. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation2006; 113: 664–670.
28.
WongTYKleinRSharrettARDuncanBBCouperDJTielschJM. Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study. JAMA2002; 287: 1153–1159.
